| CLGN Market Cap History Table | ||||
Below is a table of the CLGN market cap history going back to 12/31/2020:
Also see: CLGN Shares Outstanding History and CLGN YTD Return |
CLGN Market Cap History — CollPlant Biotechnologies Capitalization Over Time
As of 12/31/2020 CollPlant Biotechnologies has a market cap of 75.00 million. Investors often follow the CLGN market cap history to compare the size of the company over time.
This page shows CLGN market capitalization trends over time, with 1 market cap datapoints presented, dating back to 12/31/2020.
| CLGN Market Cap History Chart | |||
Mouse over chart for data details
|
| CLGN Stock Price Chart |
| About CollPlant Biotechnologies Ltd |
| CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen). We show 1 historical shares outstanding datapoints in our CLGN shares outstanding history coverage, used to compute CLGN market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CLGN market cap history over the course of time is important for investors interested in comparing CLGN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CLGN versus a peer is one thing; comparing CLGN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CLGN can fluctuate over the course of history. With this page we aim to empower investors researching CLGN by allowing them to research the CLGN market cap history. |
| CLGN Current Stock Quote |
Quotes delayed 20 minutes  Free CLGN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| CLGN Share Performance |
| Market Cap Peers |
| CollPlant Biotechnologies (CLGN) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
CLII Market Cap History CLIM Market Cap History CLIN Market Cap History CLIX Market Cap History CLLS Market Cap History CLOE Market Cap History CLPS Market Cap History CLRC Market Cap History CLRG Market Cap History CLRM Market Cap History More Miscellaneous companies » |
CLGN Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
